The federal government’s slow response to safety concerns at the country’s largest formula plant is being criticized. The first possible bacterial infection possibly related to Abbott’s formula was reported in September, but the Food and Drug Administration did not inspect the company’s Michigan plant until late January. Meg Oliver reports.
Add Comment